HemaSphere (Aug 2023)
P616: LONG-TERM FOLLOW-UP UPDATE AND MULTIVARIABLE ANALYSES OF FACTORS ASSOCIATED WITH DURATION OF RESPONSE AFTER CD19 CAR T-CELL THERAPY FOR RELAPSED/REFRACTORY CLL
- Emily Liang,
- Alexandre Hirayama,
- Erik Kimble,
- Andrew Portuguese,
- Aya Albittar,
- Aude Chapuis,
- Mazyar Shadman,
- Brian Till,
- Ryan Cassaday,
- Filippo Milano,
- Hans-Peter Kiem,
- Camesron Turtle,
- David Maloney,
- Jordan Gauthier
Affiliations
- Emily Liang
- 1 Fred Hutchinson Cancer Center, Seattle, United States
- Alexandre Hirayama
- 1 Fred Hutchinson Cancer Center, Seattle, United States
- Erik Kimble
- 1 Fred Hutchinson Cancer Center, Seattle, United States
- Andrew Portuguese
- 1 Fred Hutchinson Cancer Center, Seattle, United States
- Aya Albittar
- 1 Fred Hutchinson Cancer Center, Seattle, United States
- Aude Chapuis
- 1 Fred Hutchinson Cancer Center, Seattle, United States
- Mazyar Shadman
- 1 Fred Hutchinson Cancer Center, Seattle, United States
- Brian Till
- 1 Fred Hutchinson Cancer Center, Seattle, United States
- Ryan Cassaday
- 1 Fred Hutchinson Cancer Center, Seattle, United States
- Filippo Milano
- 1 Fred Hutchinson Cancer Center, Seattle, United States
- Hans-Peter Kiem
- 1 Fred Hutchinson Cancer Center, Seattle, United States
- Camesron Turtle
- 1 Fred Hutchinson Cancer Center, Seattle, United States
- David Maloney
- 1 Fred Hutchinson Cancer Center, Seattle, United States
- Jordan Gauthier
- 1 Fred Hutchinson Cancer Center, Seattle, United States
- DOI
- https://doi.org/10.1097/01.HS9.0000969368.47239.5b
- Journal volume & issue
-
Vol. 7
p. e472395b
Abstract
No abstracts available.
